MARKET

TLSA

TLSA

Tiziana Life Sciences Ltd Com
NASDAQ
1.780
+0.060
+3.49%
Pre Market: 1.750 -0.03 -1.69% 09:13 12/15 EST
OPEN
1.710
PREV CLOSE
1.720
HIGH
1.800
LOW
1.591
VOLUME
65.56K
TURNOVER
0
52 WEEK HIGH
2.600
52 WEEK LOW
0.6295
MARKET CAP
211.51M
P/E (TTM)
-15.6690
1D
5D
1M
3M
1Y
5Y
1D
Tiziana Life Sciences Withdraws Public Offering Amid Market Conditions
TipRanks · 3h ago
TIZIANA LIFE SCIENCES ANNOUNCES WITHDRAWAL OF PROPOSED PUBLIC OFFERING
Reuters · 4h ago
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga · 4h ago
Why MindWalk Holdings Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket
Benzinga · 6h ago
Weekly Report: what happened at TLSA last week (1208-1212)?
Weekly Report · 7h ago
Tiziana Life Sciences Files For Common Stock Offering, Size Not Disclosed
Benzinga · 2d ago
Tiziana Life Sciences Initiates Phase 2 Alzheimer’s Trial with Innovative Approach
TipRanks · 2d ago
Tiziana Life Sciences to dose first patient in Phase 2 Alzheimer’s trial
TipRanks · 2d ago
More
About TLSA
Tiziana Life Sciences Ltd. is a United Kingdom-based clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. The Company’s clinical pipeline includes drug assets for secondary progressive multiple sclerosis, Alzheimer’s, and ALS. Its lead immunotherapeutic candidate, Foralumab (TZLS-401), is being developed for Non-Active Secondary Progressive Multiple Sclerosis, Alzheimer’s and other CNS indications. Its Anti-IL-6R mAb (TZLS-501), a fully human mAb, binds to both membrane-bound and soluble forms of IL-6R, an inflammatory cytokine driving chronic inflammation associated with autoimmune and cancer, reducing circulating levels of the IL-6 cytokine. Its oncology product candidate, Milciclib, is a combination therapy for the treatment of refractory solid tumors (being cancers which are non-responsive or become resistant to treatment), especially non-small cell lung cancer (NSCLC).

Webull offers Tiziana Life Sciences Ltd - ADR stock information, including NASDAQ: TLSA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TLSA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading TLSA stock methods without spending real money on the virtual paper trading platform.